Technologies - Bristol Myers Squibb

Science Firsthand

At BMS, we are unleashing the power of digital technologies to advance our mission and vision to transform patients’ lives through science and get more medicines to more patients faster, in ways that enhance outcomes. We’re putting technology at the service of our talented professionals in every facet of our organization, helping each of our 34,000+ employees do their best work every day. Technology makes us more productive, agile and efficient through every stage of our work, from early research and discovery to drug development, manufacturing, supply chain and commercialization.

Pioneering the future of medicine

We want to accelerate our pipeline to deliver transformational medicines to patients around the globe. Pairing cutting-edge research and technology with our unmatched understanding of causal human biology, we aim to provide the best outcomes possible for patients today and in the future.

Robert Plenge, Executive Vice President, Chief Research Officer, Head of Research

The state of artificial intelligence and machine learning is similar to where we were with personal computers in the 1980’s” — we are just getting started and there is so much more to discover. Technology and digital capabilities are reshaping our work – from how we develop medicines, to how we run our core business operations, all in service to patients everywhere.

Greg Meyers, Executive Vice President, Chief Digital & Technology Officer

Our vision for AI-enabled commercialization is to position BMS as a leader in harnessing AI to increase our impact with healthcare practitioners and patients. By embedding end-to-end, data-driven solutions across our organization, we will accelerate decision making, simplify how we operate, and elevate the way we engage customers. Above all, we are cultivating a mindset of innovation and purpose; because when we innovate with intention, we change lives.

Adam Lenkowsky, Executive Vice President, Chief Commercialization Officer

Demonstrating leadership in AI-driven commercialization

Bristol Myers Squibb is taking important steps to modernize how we bring information to healthcare professionals by integrating AI across our commercialization approach. We aim is to create an end-to-end, AI-enabled model that helps us reach healthcare professionals around the world with greater accuracy, speed, and relevance to support stronger clinical decisions and provide better care for patients. This work is about more than adopting new technology. It reflects a thoughtful effort to close communication gaps, simplify complex processes, and provide personalized, science-based information at the moments when it matters most. By weaving AI into how we operate, we are strengthening our ability to respond to the needs of both providers and patients. Our mission to transform patients’ lives through science guides every step of this journey. Using AI to enhance commercialization is one way we are bringing that mission to life and helping to ensure that innovation reaches the people who depend on it.

R&D predictive technologies

At Bristol Myers Squibb, we embrace AI and data-driven decision-making across the entire R&D continuum, focusing on telling the full story from discovery to patient impact. Artificial intelligence and machine learning have become indispensable accelerators of R&D, advancing the path from laboratory discoveries to patient care at the bedside. By combining AI and machine learning with a humanistic approach to research, we’re able to harness the potential of early scientific discoveries and drive efficiencies in later stages of development, ultimately making breakthroughs more accessible to the patients who need them.

Learn more

Accelerating paths of promise: Data and predictive technology at Bristol Myers Squibb

Accelerating protein degradation science with AI and machine learning

Digital health

At Bristol Myers Squibb, our digital health technologies are helping create a step change in how health conditions are diagnosed, treated, and monitored. From wearable biosensors to patient companion apps, we’re building a future where digital solutions work alongside our medicines to deliver more precise, proactive care. We’re also transforming how we engage with clinicians, using our technologies to equip them with timely insights and decision-support tools that enhance care delivery. With over two dozen AI-enabled digital health tools in development, we’re committed to a future where patients have greater agency, better access to health information, and more collaborative conversations with providers about treatment and care decisions.

Consumer wearable technology advancements may support AFib
detection

Using the power of technology to better serve our patients

Artificial intelligence & machine learning

By uniting the expertise of our scientists, researchers, clinicians and engineers with the power of computer and data science, artificial intelligence (AI) and machine learning (ML), we’re accelerating discovery and transforming the way we work. This fusion of human ingenuity and advanced technology strengthens our ability to uncover insights faster, design smarter trials and deliver new solutions with greater precision — bringing together world-class science and innovative technology to drive meaningful progress for patients.

Leveraging AI to enhance workplace innovation & efficiency

Women innovators in AI transforming patient care